Oramed Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 5 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Oramed Pharmaceuticals Inc
TickerORMP
CIK #0001176309
CUSIP68403P104
SectorLife Sciences - Pharmaceutical Preparations
Address2 Elza Street, Jerusalem, 93706
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Oramed Pharmaceuticals Inc 2014-11-14 Exemption: 506(b) · Minimum: $5,000,000 · Remaining: $5,000,000 · Duration: One year or less · Finder's Fee: $150,000 · Revenue: No Revenues
CIK Filing 2011 - 2026
[0001176309] 10-K
[0001176309] 10-Q
[0001176309] 3
[0001176309] 4
[0001176309] 5
[0001176309] 8-K
[0001176309] D
[0001176309] SC 13D
[0001176309] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Aquamarine Financial Cayman Ltd Oramed Pharmaceuticals Inc [2026-05-15] 0.0
Oramed Pharmaceuticals Inc Lifeward Ltd [2026-05-14] 0.0
Oramed Pharmaceuticals Inc NANO Dimension Ltd [2026-01-29] 0.0
Oramed Pharmaceuticals Inc Alpha TAU Medical Ltd [2025-05-01] 0.0
Oramed Pharmaceuticals Inc Scilex Holding Co [2025-01-17] 0.0
BML Investment Partners LP Oramed Pharmaceuticals Inc [2024-09-16] 5.0
Kidron Nadav Oramed Pharmaceuticals Inc [2024-03-22] 5.7
Slager David Mark Oramed Pharmaceuticals Inc [2020-02-11] 7.4
Altium Capital Management LP Oramed Pharmaceuticals Inc [2018-07-13] 5.61
Armistice Capital LLC Oramed Pharmaceuticals Inc [2018-07-12] 4.9
Sabby Management LLC Oramed Pharmaceuticals Inc [2018-07-03] 5.53
Slager David Mark Oramed Pharmaceuticals Inc [2017-02-14] 0.9
Hefei Tianhui Incubator of Technologies Co Ltd Oramed Pharmaceuticals Inc [2016-01-06] 0.06
SANK Leonard Oramed Pharmaceuticals Inc [2014-12-15] 5.2
Marxe Austin W & Greenhouse David M Oramed Pharmaceuticals Inc [2014-02-12] 8.1
Sabby Management LLC Oramed Pharmaceuticals Inc [2013-12-31] 8.29
[2013-02-11] None
Regals Management LP Oramed Pharmaceuticals Inc [2012-04-13] 0.9
Form 3/4/5 Filer 2011 - 2026
Gabay Avraham
Oramed Pharmaceuticals Inc
Hexter Joshua
Lifeward Ltd
Kidron Miriam
Kidron Nadav
Shapiro Benjamin
Reznick Yehuda
Mayer Arie
Aghion Daniel
Sank Leonard
Silberman David
Rozov Yadin
Derovan Netanel
Rabinowitz Michael
Rakin Kevin
Rabinowitz Michael
Friedman Aviad
Xiaoming Gao
Slager David Mark
Hasleton Mark Daniel
Eisenberg Hilla
Li Xiaopeng
Zommer Yifat Hen
Law Ronald Edward
Jacob Harold
Regals Capital Management LP
Berelowitz Michael
Regals Fund LP
Ostrov Gerald M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kidron Nadav
Common Stock
2026-03-30 Tax withheld 44,818 $3.31 148,348
Kidron Miriam
Common Stock
2026-03-30 Tax withheld 435,084 $3.31 1,440,128
Kidron Miriam
Common Stock
2026-03-17 Grant 119,558 $0.00
Gabay Avraham
Common Stock
2026-03-17 Grant 95,889 $0.00
Hexter Joshua
Common Stock
2026-03-17 Grant 95,889 $0.00
Kidron Nadav
Common Stock
2026-03-17 Grant 167,005 $0.00
Kidron Nadav
Common Stock
2026-03-12 Gift 100,000 $0.00
Kidron Miriam
Common Stock
2026-01-22 Option exercise 19,000 $0.00
Kidron Nadav
Performance Stock Units · derivative
2026-01-22 Option exercise 109,000 $0.00
Gabay Avraham
Common Stock
2026-01-22 Option exercise 19,000 $0.00
Hexter Joshua
Common Stock
2026-01-22 Option exercise 19,000 $0.00
Kidron Miriam
Performance Stock Units · derivative
2026-01-22 Option exercise 19,000 $0.00
Hexter Joshua
Performance Stock Units · derivative
2026-01-22 Option exercise 19,000 $0.00
Gabay Avraham
Performance Stock Units · derivative
2026-01-22 Option exercise 19,000 $0.00
Kidron Nadav
Common Stock
2026-01-22 Option exercise 109,000 $0.00
Kidron Miriam
Common Stock
2026-01-14 Gift 86,166 $0.00
Gabay Avraham
Common Stock
2025-12-31 Grant 81,216 $0.00
Kidron Nadav
Performance Stock Units · derivative
2025-12-31 Grant 109,000 $0.00
Kidron Miriam
Performance Stock Units · derivative
2025-12-31 Grant 19,000 $0.00
Hexter Joshua
Performance Stock Units · derivative
2025-12-31 Grant 19,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 64 13,473,761
2025-12-31 57 13,333,186
2025-09-30 47 9,210,103
2025-06-30 48 7,346,545
2025-03-31 53 7,783,187
2024-12-31 56 7,703,266
2024-09-30 55 6,966,016
2024-06-30 59 5,940,786
2024-03-31 52 5,373,321
2023-12-31 56 5,283,451
2023-09-30 57 2,316,485
2023-06-30 52 2,331,248
Form 13F Holdings
Firm Period DFND Voting Shares
Sage Capital Management LLC [2026-06-30] SOLE 17,977 17,977
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 0 12,895
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 12,817 12,817
IFP Advisors LLC [2026-06-30] SOLE 500 500
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com